To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AGPAT3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
550 supporting clones for gene AGPAT3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI460808 testis .a 1 to 699 1 to 723   tiling clone,   720/725
(99 %)
47 diff
(93.6 %id)
BC040603 testis .a 6 to 2387 1 to 2382 exact tiling clone, available from MGC, AAA   2382/2382
(100 %)
1 diff
(100.0 %id)
AK125804 testis .b 1 to 3948 8 to 3955 exact tiling clone, available from FLJ,   3955/3955
(100 %)
5 diff
(99.9 %id)
DB061645 testis .b 1 to 562 8 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB228575 trachea .b 1 to 560 2 to 561   tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DA118976 cerebellum .b 379 to 938 2 to 561   capped   560/560
(100 %)
10 diff
(98.3 %id)
BG424827 Kidney, renal cell adenocarcinoma .b 2949 to 3676 1 to 726       724/1024
(70 %)
14 diff
(98.7 %id)
DB339319 testis .b 3429 to 3948 520 to 1       520/520
(100 %)
0 diff
(100 %id)
BC063552 Skin, normal .c 1 to 2332 1 to 2332 exact tiling clone, available from MGC, AAA   2332/2332
(100 %)
1 diff
(100.0 %id)
BG698693 skin .c 1 to 623 1 to 622       622/622
(100 %)
3 diff
(99.6 %id)
BG427551 Kidney .c 390 to 1068 1 to 678       678/679
(99 %)
8 diff
(98.9 %id)
DA878334 Prostate .c 390 to 941 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
BM083518 Kidney .c 391 to 980 1 to 592   tiling clone,   592/592
(100 %)
2 diff
(99.7 %id)
NM_001037553.1   .c 391 to 6825 1 to 6435 exact RefSeq,   6435/6435
(100 %)
0 diff
(100 %id)
AF156774   .d 1 to 1646 1 to 1645 exact tiling clone, AAA   1645/1645
(100 %)
3 diff
(99.9 %id)
AB040138 Liver .e 1 to 1333 1 to 1333 exact tiling clone,   1333/1333
(100 %)
0 diff
(100 %id)
DB461703 testis .f 1 to 486 1 to 486   tiling clone,   486/486
(100 %)
0 diff
(100 %id)
CD672915 eye, Iris .f 87 to 612 1 to 526       526/526
(100 %)
0 diff
(100 %id)
NM_020132.4   .f 87 to 6641 1 to 6555 exact RefSeq,   6555/6555
(100 %)
0 diff
(100 %id)
CV570456 cornea, eye .f 92 to 714 1 to 623       623/623
(100 %)
0 diff
(100 %id)
BC011971 Brain, glioblastoma with EGFR amplification .f 113 to 1600 1 to 1487 exact available from MGC, AAA   1487/1487
(100 %)
2 diff
(99.9 %id)
CN343415 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 116 to 676 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BU500684   .f 140 to 974 1 to 835       835/923
(90 %)
13 diff
(98.6 %id)
BX325280   .f 158 to 1076 1 to 919       919/919
(100 %)
2 diff
(99.8 %id)
BX401713   .f 158 to 1131 1 to 971       971/971
(100 %)
5 diff
(99.5 %id)
DR003656 hippocampus .f 187 to 661 9 to 483       475/483
(98 %)
0 diff
(100 %id)
BE794370 lung, small cell carcinoma .f 261 to 1008 14 to 762       749/762
(98 %)
8 diff
(99.0 %id)
TI_1948123454   .f 308 to 849 128 to 669   fully sequenced,   542/669
(81 %)
1 diff
(99.9 %id)
TI_1948123629   .f 308 to 1041 132 to 880       749/1450
(51 %)
25 diff
(98.3 %id)
TI_1948123792   .f 308 to 1060 127 to 882       756/1302
(58 %)
23 diff
(98.3 %id)
TI_1948123961   .f 308 to 849 129 to 671   fully sequenced,   543/671
(80 %)
10 diff
(98.6 %id)
TI_1948230236   .f 308 to 849 121 to 662   fully sequenced,   542/662
(81 %)
6 diff
(99.1 %id)
TI_1948230409   .f 308 to 1076 126 to 900       775/1194
(64 %)
20 diff
(98.4 %id)
TI_1948230575   .f 308 to 1106 121 to 916   tiling clone, fully sequenced,   796/916
(86 %)
11 diff
(98.8 %id)
TI_1948230740   .f 308 to 849 123 to 664   fully sequenced,   542/664
(81 %)
6 diff
(99.1 %id)
CV023393 mixed .f 309 to 927 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
EL737083 mixed .f 309 to 918 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
EC546331 Prostate .f 391 to 480 97 to 7       91/97
(93 %)
0 diff
(100 %id)
CX759819 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 403 to 1047 23 to 664     Submitted on the opposite strand 642/767
(83 %)
24 diff
(96.9 %id)
BF798016 lymph, lymphoma, cell line .f 423 to 893 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BI049907 placenta_normal .f 441 to 654 14 to 227       214/227
(94 %)
7 diff
(97.0 %id)
BE742623 adenocarcinoma cell line, ovary .f 466 to 1065 1 to 606       606/606
(100 %)
7 diff
(98.9 %id)
AL832919 melanoma (MeWo cell line) .f 515 to 5580 1 to 5068   available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 5068/5068
(100 %)
10 diff
(99.9 %id)
W26135 eye, retina .f 594 to 1072 22 to 509       486/530
(91 %)
26 diff
(95.1 %id)
BX281224 lymph, lymphoma, cell line .f 636 to 902 1 to 267       267/267
(100 %)
2 diff
(99.3 %id)
BM459459 lymph, lymphoma, cell line .f 639 to 1526 1 to 897       897/1063
(84 %)
20 diff
(98.2 %id)
CX758671 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 651 to 1431 3 to 779     Submitted on the opposite strand 777/791
(98 %)
13 diff
(98.4 %id)
CT001655 T-Lymphocytes .f 686 to 1349 1 to 665       665/691
(96 %)
2 diff
(99.8 %id)
AA804708 liposarcoma .f 720 to 965 1 to 246       246/246
(100 %)
9 diff
(96.4 %id)
BQ355739 head_neck .f 726 to 1335 1 to 609       609/609
(100 %)
9 diff
(98.6 %id)
BQ049014 lymph, lymphoma, cell line .f 728 to 1345 1 to 622       622/1144
(54 %)
16 diff
(98.7 %id)
BG997288 head_neck .f 741 to 1295 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
BG995044 head_neck .f 742 to 1430 1 to 687       687/703
(97 %)
19 diff
(97.3 %id)
BM931691 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 743 to 1106 27 to 390   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 364/390
(93 %)
6 diff
(98.5 %id)
BI007000 kidney_tumor .f 750 to 1097 1 to 347       347/347
(100 %)
17 diff
(95.2 %id)
AW410448 muscle, rhabdomyosarcoma .f 751 to 1375 24 to 648       625/648
(96 %)
8 diff
(98.8 %id)
AW411232 muscle, rhabdomyosarcoma .f 751 to 1398 9 to 656       648/656
(98 %)
6 diff
(99.1 %id)
BF305599 muscle, rhabdomyosarcoma .f 751 to 1345 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
BI114205 muscle, rhabdomyosarcoma .f 751 to 1157 1 to 409       409/964
(42 %)
9 diff
(99.1 %id)
BG541849 lung .f 766 to 1590 1 to 819       819/896
(91 %)
29 diff
(96.8 %id)
BE298682 muscle, rhabdomyosarcoma .f 772 to 1392 1 to 622       622/622
(100 %)
2 diff
(99.7 %id)
BU535433 adenocarcinoma, cell line, breast .f 785 to 1346 1 to 564       564/782
(72 %)
5 diff
(99.4 %id)
TI_1948123455   .f 788 to 1437 780 to 130   fully sequenced,   651/780
(83 %)
0 diff
(100 %id)
TI_1948123962   .f 788 to 1443 787 to 122   fully sequenced,   666/787
(84 %)
2 diff
(99.8 %id)
TI_1948230237   .f 788 to 1443 775 to 120   fully sequenced,   656/775
(84 %)
0 diff
(100 %id)
TI_1948230741   .f 788 to 1443 778 to 123   fully sequenced,   656/778
(84 %)
0 diff
(100 %id)
BF197265 pooled .f 916 to 1258 362 to 20       343/362
(94 %)
0 diff
(100 %id)
BX328290   .f 973 to 1903 1 to 921   tiling clone,   921/1002
(91 %)
59 diff
(94.2 %id)
AA128849 Pancreas .f 998 to 1349 1 to 357       357/383
(93 %)
6 diff
(98.5 %id)
BG698104 skin .f 1001 to 1836 1 to 828       828/1170
(70 %)
27 diff
(97.7 %id)
AA413377   .f 1021 to 1214 201 to 12     Submitted on the opposite strand 190/201
(94 %)
8 diff
(96.1 %id)
BF915644 uterus_tumor .f 1034 to 1502 469 to 1     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
TI_1948230576   .f 1045 to 1443 521 to 122   fully sequenced,   400/521
(76 %)
0 diff
(100 %id)
BM675712 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1045 to 1439 398 to 4   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 395/398
(99 %)
0 diff
(100 %id)
AI565184 pooled .f 1061 to 1240 180 to 1       180/180
(100 %)
0 diff
(100 %id)
BF913942 uterus_tumor .f 1093 to 1501 410 to 2     Submitted on the opposite strand 409/410
(99 %)
5 diff
(98.8 %id)
CA396979 eye, RPE/choroid .f 1096 to 1592 11 to 507       497/507
(98 %)
6 diff
(98.9 %id)
BF914866 uterus_tumor .f 1122 to 1575 454 to 1     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
AI935492 Kidney .f 1163 to 1424 262 to 1       262/262
(100 %)
2 diff
(99.3 %id)
AW386009 leiomios .f 1172 to 1300 1 to 129       129/131
(98 %)
8 diff
(93.9 %id)
BM476336 duodenal adenocarcinoma, cell line, small intestine .f 1231 to 2234 1 to 1001       1001/1082
(92 %)
29 diff
(97.4 %id)
BF342652 brain, glioblastoma with EGFR amplification .f 1238 to 1684 1 to 452       452/452
(100 %)
7 diff
(98.5 %id)
CN343418 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 1272 to 1958 1 to 688       688/688
(100 %)
3 diff
(99.6 %id)
T55548 fetal spleen, Spleen .f 1295 to 1599 329 to 20   AAA   310/338
(91 %)
11 diff
(96.8 %id)
DB527124 testis .f 1346 to 1771 1 to 426     Submitted on the opposite strand 426/432
(98 %)
4 diff
(99.1 %id)
BM561609 blood, natural killer cells, cell line .f 1349 to 2323 7 to 992   tiling clone,   986/1061
(92 %)
29 diff
(97.3 %id)
BQ647887 hepatocellular carcinoma, cell line, Liver .f 1349 to 2238 28 to 921       894/981
(91 %)
14 diff
(98.6 %id)
CA432476 cell lines, Chondrosarcoma .f 1360 to 2177 834 to 19   AAA   816/816
(100 %)
4 diff
(99.6 %id)
BI259282 cervical carcinoma cell line, cervix .f 1384 to 2208 1 to 831       831/900
(92 %)
17 diff
(98.2 %id)
BQ309280 breast .f 1407 to 1821 1 to 415       415/415
(100 %)
15 diff
(96.4 %id)
CB159822 Liver .f 1430 to 1978 549 to 1     Submitted on the opposite strand 549/549
(100 %)
0 diff
(100 %id)
BU619923 cell lines, Chondrosarcoma .f 1455 to 2177 741 to 19   AAA   723/723
(100 %)
1 diff
(99.9 %id)
BU622423 cell lines, Chondrosarcoma .f 1471 to 2177 724 to 19   AAA   706/706
(100 %)
1 diff
(99.9 %id)
AL120092 amygdala .f 1554 to 2063 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
BG697199 skin .f 1563 to 2343 1 to 789       789/789
(100 %)
18 diff
(97.8 %id)
BG326986 Kidney, renal cell adenocarcinoma .f 1564 to 2246 1 to 682       682/683
(99 %)
2 diff
(99.8 %id)
BG177594 lymph, lymphoma, cell line .f 1566 to 2204 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
BF125090 melanotic melanoma, skin .f 1582 to 2357 1 to 778       778/979
(79 %)
17 diff
(98.3 %id)
BG698592 skin .f 1594 to 2093 30 to 533       504/533
(94 %)
6 diff
(98.9 %id)
BM795529 stomach .f 1596 to 2068 1 to 474       474/474
(100 %)
8 diff
(98.4 %id)
CN343416 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1598 to 2050 1 to 453       453/453
(100 %)
1 diff
(99.8 %id)
BQ707673 Spleen .f 1608 to 2478 1 to 886       886/969
(91 %)
40 diff
(95.9 %id)
BQ708388 Spleen .f 1608 to 2323 1 to 717       717/899
(79 %)
19 diff
(97.9 %id)
AW299940 Kidney .f 1700 to 2195 502 to 7       496/502
(98 %)
0 diff
(100 %id)
BF195896 Kidney .f 1702 to 2184 487 to 4       484/487
(99 %)
0 diff
(100 %id)
BQ216488 large cell carcinoma, lung .f 1747 to 2576 8 to 842       835/882
(94 %)
6 diff
(99.4 %id)
AI288236 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1767 to 2177 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
DA380911 thalamus .f 1770 to 2397 2 to 629   capped   628/628
(100 %)
0 diff
(100 %id)
DA753964   .f 1778 to 2278 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA437639 tongue, tumor tissue .f 1779 to 2322 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA658684   .f 1781 to 2346 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AL109795   .f 1782 to 3718 1 to 1937   tiling clone, AAA   1937/1937
(100 %)
1 diff
(100.0 %id)
R35127 whole brain .f 1782 to 2192 1 to 416       416/422
(98 %)
14 diff
(96.7 %id)
H12122 whole brain .f 1782 to 2211 1 to 433       433/433
(100 %)
8 diff
(98.2 %id)
R84552 brain .f 1782 to 2184 1 to 404       404/405
(99 %)
5 diff
(98.8 %id)
BM455810 lymph, lymphoma, cell line .f 1784 to 2619 1 to 848       848/1060
(80 %)
20 diff
(98.2 %id)
BE218362 carcinoid, lung .f 1786 to 2289 1 to 504     Submitted on the opposite strand 504/504
(100 %)
0 diff
(100 %id)
BU429170 lymph .f 1788 to 2243 1 to 456       456/456
(100 %)
6 diff
(98.7 %id)
AK026135   .f 1789 to 3718 1 to 1931   available from FLJ, AAA   1931/1931
(100 %)
1 diff
(100.0 %id)
DA687931   .f 1790 to 2208 2 to 420   capped   419/419
(100 %)
1 diff
(99.8 %id)
BI194792 epithelioid carcinoma cell line, Pancreas .f 1791 to 2418 43 to 674       632/676
(93 %)
14 diff
(98.0 %id)
DB097409 testis .f 1792 to 2362 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
TI_154150098   .f 1794 to 2464 79 to 750       672/786
(85 %)
41 diff
(94.8 %id)
BM930357 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1799 to 2177 1 to 379   AAA   379/379
(100 %)
2 diff
(99.5 %id)
BQ636704 eye, retina .f 1802 to 2287 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BM050263 epithelioid carcinoma cell line, Pancreas .f 1803 to 2273 1 to 473       473/862
(54 %)
4 diff
(99.6 %id)
BI224203 cervical carcinoma cell line, cervix .f 1817 to 2431 1 to 613       613/682
(89 %)
21 diff
(97.0 %id)
CB216988 normal endometrium, mid-secretory phase,cycle day 23, uterus .f 1819 to 2519 1 to 701       701/701
(100 %)
1 diff
(99.9 %id)
BI757547 brain .f 1836 to 2595 1 to 761       761/761
(100 %)
21 diff
(97.3 %id)
TI_57220421   .f 1836 to 2595 35 to 795       761/795
(95 %)
6 diff
(99.3 %id)
CN343419 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1845 to 2280 1 to 436       436/436
(100 %)
0 diff
(100 %id)
BG420187 Kidney, renal cell adenocarcinoma .f 1848 to 2483 1 to 636       636/637
(99 %)
2 diff
(99.7 %id)
DA243699 brain .f 1860 to 2432 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BM795298 stomach .f 1860 to 2470 1 to 613       613/613
(100 %)
2 diff
(99.7 %id)
BU857268 adenocarcinoma, cell line, breast .f 1885 to 2751 1 to 879       879/927
(94 %)
15 diff
(98.4 %id)
BU857269 adenocarcinoma, cell line, breast .f 1885 to 2758 1 to 880       880/917
(95 %)
25 diff
(97.3 %id)
AI078468 liver and spleen .f 1887 to 2283 417 to 21       397/417
(95 %)
0 diff
(100 %id)
T96134 liver and spleen .f 1888 to 2231 344 to 1       344/346
(99 %)
10 diff
(97.2 %id)
BI860457 breast, mammary adenocarcinoma, cell line .f 1901 to 2490 16 to 606       591/608
(97 %)
7 diff
(98.9 %id)
TI_57189410   .f 1901 to 2490 63 to 653       591/609
(97 %)
7 diff
(98.9 %id)
BG413463 pooled .f 1907 to 2394 506 to 19   AAA   488/488
(100 %)
0 diff
(100 %id)
BQ945727 epidermoid carcinoma, cell line, lung .f 1938 to 2549 1 to 622       622/997
(62 %)
14 diff
(98.6 %id)
BE252130 eye, retinoblastoma .f 1940 to 2426 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BE257404 eye, retinoblastoma .f 1942 to 2436 1 to 495       495/497
(99 %)
2 diff
(99.6 %id)
DA202196 brain .f 1968 to 2551 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BX361142 Placenta Cot 25-normalized .f 1979 to 3027 1 to 1033       1033/1074
(96 %)
7 diff
(99.4 %id)
Z43695 brain, total brain .f 1991 to 2342 1 to 351       351/351
(100 %)
2 diff
(99.5 %id)
BU429278 lymph .f 2000 to 2339 1 to 340       340/340
(100 %)
5 diff
(98.6 %id)
TI_154150275   .f 2007 to 2584 80 to 660       581/735
(79 %)
16 diff
(97.9 %id)
T83375 liver and spleen .f 2021 to 2283 261 to 1       261/261
(100 %)
8 diff
(97.0 %id)
CR740688 heart .f 2033 to 2526 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
BI255158 cervical carcinoma cell line, cervix .f 2060 to 2797 1 to 747       747/751
(99 %)
23 diff
(97.0 %id)
BM988068 mixed .f 2083 to 2416 352 to 19   AAA   334/334
(100 %)
3 diff
(99.2 %id)
BM824826 Ascites, stomach .f 2083 to 2217 1 to 135       135/135
(100 %)
2 diff
(98.6 %id)
AA133135 Pancreas .f 2109 to 2439 366 to 31       336/371
(90 %)
0 diff
(100 %id)
BG421888 Kidney, renal cell adenocarcinoma .f 2122 to 2904 1 to 759       759/947
(80 %)
23 diff
(97.6 %id)
BQ669168 epidermoid carcinoma, cell line, salivary gland .f 2123 to 3008 1 to 889       889/890
(99 %)
12 diff
(98.7 %id)
BQ639142 eye, retina .f 2138 to 2738 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BQ636040 eye, retina .f 2139 to 2745 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
BE869182 adenocarcinoma, colon .f 2141 to 2881 1 to 725       725/930
(77 %)
63 diff
(93.3 %id)
BG759752 B-cells, primary B-cells from tonsils (cell line) .f 2196 to 2803 1 to 609       609/609
(100 %)
3 diff
(99.6 %id)
AA158637 Pancreas .f 2260 to 2670 1 to 416       416/423
(98 %)
22 diff
(94.8 %id)
DB167929 kidney, tumor tissue .f 2328 to 2760 2 to 435   capped   434/434
(100 %)
1 diff
(99.8 %id)
BG696236 skin .f 2352 to 2950 1 to 593       593/602
(98 %)
13 diff
(97.9 %id)
BX350687   .f 2354 to 2874 524 to 1       524/617
(84 %)
22 diff
(96.5 %id)
BQ638021 eye, retina .f 2364 to 2868 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BM741926 Ascites, stomach .f 2366 to 2968 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
BM783941 Ascites, stomach .f 2366 to 3008 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BM746216 stomach .f 2366 to 2803 1 to 438       438/438
(100 %)
2 diff
(99.6 %id)
BM771979 stomach .f 2366 to 2941 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BM741831 stomach .f 2367 to 2831 1 to 464       464/464
(100 %)
3 diff
(99.4 %id)
BE543123 cervical carcinoma cell line, cervix .f 2377 to 2846 1 to 484       484/746
(64 %)
25 diff
(96.7 %id)
BF304087 muscle, rhabdomyosarcoma .f 2378 to 3086 1 to 700       700/763
(91 %)
18 diff
(97.7 %id)
BQ709017 Spleen .f 2388 to 3159 20 to 796       777/963
(80 %)
34 diff
(96.5 %id)
AW291796   .f 2418 to 2838 1 to 421     Submitted on the opposite strand 421/421
(100 %)
6 diff
(98.6 %id)
BG420576 Kidney, renal cell adenocarcinoma .f 2422 to 3197 1 to 779       779/934
(83 %)
32 diff
(96.6 %id)
BG697519 skin .f 2423 to 2953 1 to 536       536/674
(79 %)
21 diff
(96.9 %id)
BQ231526 melanotic melanoma, skin .f 2423 to 3276 1 to 870       870/899
(96 %)
45 diff
(95.0 %id)
CF454519 peripheral nervous system .f 2425 to 3158 30 to 756       727/863
(84 %)
12 diff
(98.7 %id)
CB126039 cervix, Uterine .f 2426 to 2806 1 to 381       381/381
(100 %)
3 diff
(99.3 %id)
AI431799 Kidney .f 2499 to 2940 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
TI_45211676   .f 2500 to 3152 81 to 729       649/731
(88 %)
6 diff
(99.2 %id)
AI190103 heart .f 2503 to 2943 441 to 1       441/441
(100 %)
9 diff
(98.0 %id)
BG753884 B-cells, primary B-cells from tonsils (cell line) .f 2505 to 3182 7 to 684   available from MGC,   678/684
(99 %)
6 diff
(99.2 %id)
BG714319 brain, hypothalamus .f 2506 to 3251 5 to 745       741/745
(99 %)
6 diff
(99.2 %id)
BI602106 brain, hypothalamus .f 2506 to 3152 5 to 647       643/649
(99 %)
11 diff
(98.4 %id)
BI547064 brain, hippocampus .f 2507 to 3321 1 to 812       812/812
(100 %)
20 diff
(97.6 %id)
DB493187 hypothalamus .f 2510 to 2886 1 to 372       372/374
(99 %)
9 diff
(97.6 %id)
DB493188 hypothalamus .f 2510 to 2931 1 to 417       417/417
(100 %)
21 diff
(95.0 %id)
DB500720 hypothalamus .f 2510 to 2978 1 to 465       465/465
(100 %)
4 diff
(99.2 %id)
BC026047 Primary B-Cells from Tonsils .f 2510 to 3718 11 to 1219   available from MGC, AAA   1209/1209
(100 %)
1 diff
(100.0 %id)
TI_44167745   .f 2511 to 3321 125 to 932       808/932
(86 %)
6 diff
(99.4 %id)
BM465638 eye, retinoblastoma .f 2513 to 3277 23 to 790       768/1052
(73 %)
6 diff
(99.5 %id)
CF140687 CNCAP(3)T-225 cell line, Prostate .f 2519 to 2838 8 to 327       320/327
(97 %)
6 diff
(98.2 %id)
TI_154171278   .f 2519 to 3157 68 to 707       640/954
(67 %)
32 diff
(96.7 %id)
AI144224 heart .f 2523 to 2936 414 to 1       414/414
(100 %)
5 diff
(98.8 %id)
BM564637 duodenal adenocarcinoma, cell line, small intestine .f 2525 to 3269 14 to 765       752/1120
(67 %)
18 diff
(98.4 %id)
ES310372 scalp interfollicular dermis, skin .f 2534 to 3039 143 to 654       512/656
(78 %)
12 diff
(98.2 %id)
TI_151770329   .f 2556 to 3109 100 to 660       561/1384
(40 %)
33 diff
(97.7 %id)
DA256467 caudate nucleus .f 2586 to 3143 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BG421100 Kidney, renal cell adenocarcinoma .f 2593 to 3358 1 to 759       759/1088
(69 %)
30 diff
(97.3 %id)
BF128579 B-cells, primary B-cells from tonsils (cell line) .f 2611 to 3307 1 to 692       692/932
(74 %)
14 diff
(98.5 %id)
BE273719 Kidney, renal cell adenocarcinoma .f 2613 to 3307 1 to 702       702/710
(98 %)
25 diff
(96.5 %id)
BM050917 eye, normal pigmented retinal epithelium .f 2624 to 3499 1 to 871       871/888
(98 %)
33 diff
(96.3 %id)
BQ887806 eye, normal pigmented retinal epithelium .f 2624 to 3276 9 to 670       662/947
(69 %)
19 diff
(98.0 %id)
BX420759 brain, fetal brain .f 2638 to 3698 1051 to 1       1051/1135
(92 %)
18 diff
(98.5 %id)
DB483050 hippocampus .f 2645 to 3132 1 to 489       489/489
(100 %)
6 diff
(98.8 %id)
BX401712   .f 2684 to 3268 999 to 418       582/999
(58 %)
0 diff
(100 %id)
BX325279   .f 2693 to 3687 988 to 1       988/990
(99 %)
9 diff
(99.1 %id)
TI_154102006   .f 2782 to 3718 982 to 57   AAA   926/960
(96 %)
25 diff
(97.4 %id)
BF570297 Kidney, renal carcinoma (ascites) .f 2785 to 3664 880 to 1       880/968
(90 %)
36 diff
(96.3 %id)
CN401190 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 2795 to 3314 1 to 520       520/520
(100 %)
0 diff
(100 %id)
DA114223 cerebellum .f 2816 to 3369 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CA950032 Pancreas, Purified pancreatic islet .f 2820 to 3271 1 to 452       452/452
(100 %)
0 diff
(100 %id)
DA526082 brain .f 2831 to 3396 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BE909726 epithelioid carcinoma, Pancreas .f 2836 to 3542 1 to 703       703/875
(80 %)
23 diff
(97.4 %id)
BC013167 Adrenal cortex, carcinoma .f 2836 to 4444 1 to 1607   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1607/1607
(100 %)
7 diff
(99.6 %id)
BF793678 adrenal cortex carcinoma, cell line, adrenal gland .f 2836 to 3678 1 to 837   available from MGC,   837/880
(95 %)
23 diff
(97.4 %id)
AJ708888 heart .f 2840 to 3367 551 to 24     Submitted on the opposite strand 528/551
(95 %)
0 diff
(100 %id)
BE563344 adenocarcinoma, Pancreas .f 2848 to 3562 1 to 721       721/754
(95 %)
15 diff
(98.1 %id)
BY798438 eye .f 2849 to 3404 13 to 570       558/570
(97 %)
6 diff
(99.0 %id)
TI_149302349   .f 2849 to 3718 924 to 61   AAA   864/977
(88 %)
15 diff
(98.5 %id)
CK903122 Pancreas, Purified pancreatic islet .f 2855 to 3338 1 to 485     Submitted on the opposite strand 485/485
(100 %)
3 diff
(99.4 %id)
BQ679432 melanotic melanoma, cell line, skin .f 2864 to 3719 18 to 880   AAA   863/880
(98 %)
6 diff
(99.4 %id)
BQ892923 melanotic melanoma, cell line, skin .f 2865 to 3724 9 to 873       865/894
(96 %)
15 diff
(98.4 %id)
BU196613 melanotic melanoma, cell line, skin .f 2865 to 3595 1 to 732       732/933
(78 %)
18 diff
(98.1 %id)
BQ679686 melanotic melanoma, cell line, skin .f 2865 to 3516 1 to 652       652/950
(68 %)
19 diff
(98.0 %id)
BQ677363 melanotic melanoma, cell line, skin .f 2865 to 3593 1 to 735       735/927
(79 %)
8 diff
(99.2 %id)
BE151048 head_neck .f 2866 to 3314 464 to 15     Submitted on the opposite strand 450/464
(96 %)
23 diff
(95.1 %id)
BQ683808 melanotic melanoma, cell line, skin .f 2866 to 3715 1 to 855       855/923
(92 %)
15 diff
(98.4 %id)
FN146160 breast carcinoma .f 2876 to 2977 104 to 1     Submitted on the opposite strand 104/106
(98 %)
2 diff
(98.2 %id)
DA386369 thalamus .f 2883 to 3468 2 to 587   capped   586/586
(100 %)
4 diff
(99.4 %id)
BG421610 Kidney, renal cell adenocarcinoma .f 2910 to 3676 1 to 747       747/917
(81 %)
13 diff
(98.6 %id)
BE150977 head_neck .f 2922 to 3355 1 to 436       436/444
(98 %)
19 diff
(95.8 %id)
TI_154186818   .f 2949 to 3807 36 to 886       851/996
(85 %)
30 diff
(97.0 %id)
CF125284 Chondrosarcoma Lung Metastasis cell lines, lung .f 2951 to 3512 1 to 561       561/561
(100 %)
4 diff
(99.3 %id)
BI481207 Native Retinal Pigment Epithelium sheets, retina .f 2959 to 3469 12 to 529       518/529
(97 %)
6 diff
(98.9 %id)
H23846 brain .f 2964 to 3328 1 to 364       364/364
(100 %)
13 diff
(96.5 %id)
W16641 lung .f 2966 to 3325 15 to 369       355/369
(96 %)
6 diff
(98.4 %id)
BG675009 skin .f 2978 to 3730 1 to 754       754/846
(89 %)
12 diff
(98.6 %id)
BM691219 eye, RPE and Choroid .f 2982 to 3468 3 to 489   fully sequenced,   487/489
(99 %)
5 diff
(99.0 %id)
AV723327 hypothalamus .f 3008 to 3410 1 to 400       400/418
(95 %)
10 diff
(97.7 %id)
BC004413 Pancreas, adenocarcinoma .f 3008 to 3829 1 to 822   available from MGC, AAA   822/822
(100 %)
1 diff
(99.9 %id)
BM980566 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 3017 to 3718 722 to 19   AAA   704/704
(100 %)
4 diff
(99.5 %id)
CA445359 Chondrosarcoma, Left Pubic Bone .f 3023 to 3718 715 to 19   AAA   697/697
(100 %)
7 diff
(99.0 %id)
BE737251 adenocarcinoma, Pancreas .f 3024 to 3733 28 to 733   available from MGC,   706/913
(77 %)
15 diff
(98.4 %id)
AL120093 amygdala .f 3030 to 3680 652 to 1       652/652
(100 %)
3 diff
(99.6 %id)
BG394209 eye, retinoblastoma .f 3030 to 3718 1 to 689   AAA   689/689
(100 %)
5 diff
(99.3 %id)
BG471477 eye, retinoblastoma .f 3031 to 3720 1 to 690       690/707
(97 %)
2 diff
(99.8 %id)
BG473920 eye, retinoblastoma .f 3031 to 3717 1 to 696       696/908
(76 %)
12 diff
(98.7 %id)
CB047766 Kidney .f 3042 to 3718 701 to 25   AAA   677/677
(100 %)
0 diff
(100 %id)
BU631353 cell lines, Chondrosarcoma .f 3042 to 3718 695 to 19   AAA   677/677
(100 %)
2 diff
(99.8 %id)
BE251051 eye, retinoblastoma .f 3052 to 3602 1 to 556       556/556
(100 %)
7 diff
(98.8 %id)
BE251324 eye, retinoblastoma .f 3052 to 3709 1 to 654       654/659
(99 %)
5 diff
(99.3 %id)
EC517846 Prostate .f 3059 to 3155 18 to 115       98/115
(85 %)
6 diff
(94.8 %id)
DB482035 hippocampus .f 3075 to 3555 1 to 481       481/481
(100 %)
3 diff
(99.4 %id)
BQ574417 Chondrosarcoma Grade II, Left Pelvis .f 3076 to 3718 661 to 19   AAA   643/643
(100 %)
4 diff
(99.4 %id)
BQ006665 Chondrosarcoma, Left Pelvis .f 3103 to 3718 630 to 19   AAA   612/615
(99 %)
4 diff
(99.4 %id)
BE891916 melanotic melanoma, skin .f 3109 to 3543 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
H59487 liver and spleen .f 3130 to 3503 1 to 377       377/396
(95 %)
13 diff
(96.8 %id)
H48853 liver and spleen .f 3130 to 3592 1 to 468       468/470
(99 %)
22 diff
(95.4 %id)
AI961857 adenocarcinoma, Pancreas .f 3135 to 3395 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AW411233 muscle, rhabdomyosarcoma .f 3150 to 3718 588 to 20   AAA   569/569
(100 %)
4 diff
(99.3 %id)
T79101 liver and spleen .f 3155 to 3375 1 to 226   fully sequenced,   226/226
(100 %)
5 diff
(97.8 %id)
BQ637659 eye, retina .f 3156 to 3589 1 to 434       434/434
(100 %)
1 diff
(99.8 %id)
BG333335 large cell carcinoma, lung .f 3156 to 3806 1 to 654       654/886
(73 %)
10 diff
(98.9 %id)
BE669426 carcinoid, lung .f 3162 to 3593 9 to 440     Submitted on the opposite strand 432/440
(98 %)
6 diff
(98.7 %id)
BG420226 Kidney, renal cell adenocarcinoma .f 3163 to 3757 1 to 593       593/874
(67 %)
9 diff
(99.0 %id)
EB386429 eye, optic nerve .f 3166 to 3740 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BQ640134 eye, retina .f 3171 to 3666 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BP395185 pancreatic islet .f 3173 to 3698 1 to 527     Submitted on the opposite strand 527/527
(100 %)
1 diff
(99.9 %id)
BM929655 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 3176 to 3718 1 to 543   fully sequenced, AAA   543/543
(100 %)
1 diff
(99.9 %id)
T96084 liver and spleen .f 3179 to 3478 8 to 312   fully sequenced,   305/312
(97 %)
11 diff
(96.5 %id)
R08804 liver and spleen .f 3184 to 3427 1 to 252   fully sequenced,   252/252
(100 %)
7 diff
(97.3 %id)
R11394 liver and spleen .f 3184 to 3452 1 to 280   fully sequenced,   280/280
(100 %)
12 diff
(95.8 %id)
AI262922 Kidney .f 3185 to 3718 530 to 1       530/544
(97 %)
7 diff
(98.8 %id)
BE386139 melanotic melanoma, skin .f 3200 to 3854 1 to 648       648/699
(92 %)
21 diff
(97.0 %id)
BE728118 melanotic melanoma, skin .f 3200 to 3940 1 to 732       732/973
(75 %)
27 diff
(97.3 %id)
BE384701 melanotic melanoma, skin .f 3201 to 3871 1 to 667       667/749
(89 %)
22 diff
(97.1 %id)
BM545012 ovary (pool of 3) .f 3202 to 3759 20 to 578       559/582
(96 %)
13 diff
(97.8 %id)
CA943837 Pancreas, Purified pancreatic islet .f 3220 to 3720 504 to 4       501/504
(99 %)
0 diff
(100 %id)
CF552058 Pooled muscle (cardiac and skeletal) .f 3223 to 4077 28 to 891       864/891
(96 %)
6 diff
(99.4 %id)
BU625967 cell lines, Enchondroma .f 3226 to 3718 512 to 19   AAA   494/494
(100 %)
3 diff
(99.4 %id)
BF438713 brain, glioblastoma (pooled) .f 3227 to 3718 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AW615395 Kidney .f 3228 to 3719 493 to 1       493/493
(100 %)
4 diff
(99.2 %id)
BM692819 eye, Retina Foveal and Macular .f 3237 to 3695 1 to 459       459/464
(98 %)
2 diff
(99.6 %id)
BE327238 carcinoid, lung .f 3241 to 3717 477 to 1       477/477
(100 %)
0 diff
(100 %id)
TI_149272985   .f 3251 to 3718 549 to 82   AAA   468/910
(51 %)
0 diff
(100 %id)
BU675458 lung, Primary Lung Epithelial Cells .f 3251 to 3718 486 to 19   AAA   468/476
(98 %)
0 diff
(100 %id)
BF802192 colon_ins .f 3255 to 3663 1 to 408       408/408
(100 %)
16 diff
(96.1 %id)
AW082112 esophagus, squamous cell carcinoma .f 3257 to 3720 465 to 2       464/468
(99 %)
0 diff
(100 %id)
BF446628 carcinoid, lung .f 3257 to 3720 465 to 2       464/467
(99 %)
0 diff
(100 %id)
BM671865 eye, RPE and Choroid .f 3264 to 3718 473 to 19   AAA   455/464
(98 %)
2 diff
(99.6 %id)
AW272256 Kidney .f 3265 to 3718 465 to 12   AAA   454/454
(100 %)
2 diff
(99.6 %id)
AI982875 brain, three pooled meningiomas .f 3269 to 3718 461 to 12   AAA   450/450
(100 %)
7 diff
(98.5 %id)
N78731 lung .f 3271 to 3718 448 to 1       448/448
(100 %)
2 diff
(99.6 %id)
BF057697 pooled germ cell tumors .f 3275 to 3718 457 to 14   AAA   444/444
(100 %)
0 diff
(100 %id)
AI401198 brain, glioblastoma (pooled) .f 3276 to 3720 449 to 5       445/449
(99 %)
0 diff
(100 %id)
BE208093 Kidney, renal cell adenocarcinoma .f 3279 to 3720 445 to 4       442/445
(99 %)
0 diff
(100 %id)
BX334225 Neuroblastoma Cot 50-normalized .f 3281 to 3720 1 to 439       439/439
(100 %)
4 diff
(99.1 %id)
AW410449 muscle, rhabdomyosarcoma .f 3282 to 3718 469 to 33   AAA   437/437
(100 %)
2 diff
(99.6 %id)
BQ433507 melanotic melanoma, skin .f 3286 to 3870 1 to 594       594/1037
(57 %)
19 diff
(98.2 %id)
AW614447 Kidney .f 3288 to 3719 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AV717847   .f 3296 to 3717 1 to 422   AAA   422/422
(100 %)
4 diff
(99.1 %id)
DB557224 hypothalamus .f 3297 to 3720 1 to 421     Submitted on the opposite strand 421/425
(99 %)
35 diff
(91.8 %id)
AI819455 lymph node, lymphoma, follicular mixed small and largecell .f 3312 to 3720 411 to 3       409/411
(99 %)
0 diff
(100 %id)
R85941 brain .f 3319 to 3709 413 to 14       400/413
(96 %)
0 diff
(100 %id)
AI244974 Kidney .f 3323 to 3718 396 to 1       396/398
(99 %)
0 diff
(100 %id)
AA159038 Pancreas .f 3328 to 3719 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
BG741049 skin .f 3330 to 4254 1 to 916       916/931
(98 %)
35 diff
(96.3 %id)
DB149789 thymus .f 3335 to 3836 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
AA962156 Kidney .f 3341 to 3720 381 to 2       380/381
(99 %)
0 diff
(100 %id)
T78619 liver and spleen .f 3345 to 3720 398 to 1   fully sequenced,   398/398
(100 %)
27 diff
(93.3 %id)
AW970279   .f 3348 to 3707 370 to 11     Submitted on the opposite strand 360/443
(81 %)
0 diff
(100 %id)
AW970360   .f 3348 to 3717 370 to 1     Submitted on the opposite strand 370/499
(74 %)
2 diff
(99.6 %id)
AW449179   .f 3349 to 3718 387 to 18   AAA   370/370
(100 %)
2 diff
(99.5 %id)
AI091751 heart .f 3352 to 3719 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AI093844 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 3353 to 3718 383 to 18   AAA   366/366
(100 %)
0 diff
(100 %id)
AI193024 lung .f 3360 to 3711 379 to 28   AAA   352/359
(98 %)
12 diff
(96.7 %id)
AI208891   .f 3360 to 3720 368 to 8       361/368
(98 %)
0 diff
(100 %id)
AI249378 adenocarcinoma, Pancreas .f 3360 to 3720 362 to 2       361/362
(99 %)
0 diff
(100 %id)
AI582851 anaplastic oligodendroglioma, brain .f 3360 to 3711 360 to 8       353/360
(98 %)
0 diff
(100 %id)
R49515 whole brain .f 3361 to 3720 371 to 7       365/412
(88 %)
0 diff
(100 %id)
AI913879 colon .f 3361 to 3720 360 to 1       360/360
(100 %)
4 diff
(98.9 %id)
AI590350 Kidney .f 3365 to 3720 360 to 5       356/360
(98 %)
0 diff
(100 %id)
Z39755 brain, total brain .f 3367 to 3718 352 to 1       352/352
(100 %)
0 diff
(100 %id)
BF529405 anaplastic oligodendroglioma with 1p/19qloss, brain .f 3373 to 3888 1 to 523       523/556
(94 %)
13 diff
(97.7 %id)
R07189 liver and spleen .f 3386 to 3712 340 to 11       330/396
(83 %)
0 diff
(100 %id)
T98296 liver and spleen .f 3391 to 3713 337 to 9       329/341
(96 %)
0 diff
(100 %id)
R08805 liver and spleen .f 3397 to 3718 333 to 5   fully sequenced,   329/333
(98 %)
7 diff
(97.9 %id)
AA534524 colon .f 3398 to 3718 321 to 1       321/321
(100 %)
3 diff
(99.1 %id)
BM760265 lymph node, stomach .f 3398 to 3711 1 to 314       314/314
(100 %)
1 diff
(99.7 %id)
BG110513 Bone, osteosarcoma, cell line .f 3404 to 4130 1 to 716       716/941
(76 %)
6 diff
(99.4 %id)
AW025513 Kidney .f 3417 to 3718 325 to 23   AAA   303/303
(100 %)
0 diff
(100 %id)
R14889 liver and spleen .f 3422 to 3720 308 to 1   fully sequenced,   308/308
(100 %)
7 diff
(97.8 %id)
AW237374 Kidney .f 3423 to 3720 303 to 6       298/303
(98 %)
0 diff
(100 %id)
BF431670 Kidney .f 3423 to 3718 310 to 15   AAA   296/296
(100 %)
2 diff
(99.4 %id)
DA866674 Prostate .f 3426 to 3957 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BM683605 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 3432 to 3718 305 to 19   fully sequenced, AAA   287/287
(100 %)
0 diff
(100 %id)
BF197434 Kidney .f 3433 to 3718 289 to 4       286/289
(98 %)
0 diff
(100 %id)
DA820714 pericardium .f 3435 to 3996 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BG674192 skin .f 3437 to 4286 1 to 861       861/863
(99 %)
46 diff
(94.7 %id)
BU726558 eye, RPE and Choroid .f 3438 to 3718 298 to 18   fully sequenced, AAA   281/281
(100 %)
1 diff
(99.7 %id)
T96085 liver and spleen .f 3448 to 3704 268 to 1   fully sequenced,   268/268
(100 %)
3 diff
(98.9 %id)
DA620763   .f 3458 to 4040 2 to 584   tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
AI373059 Kidney .f 3463 to 3720 263 to 6       258/263
(98 %)
0 diff
(100 %id)
AI084642 senescent fibroblast .f 3479 to 3718 261 to 22   AAA   240/240
(100 %)
14 diff
(94.2 %id)
CN386669 embryonic stem cells, DMSO-treated H9 cellline .f 3500 to 3797 1 to 298       298/298
(100 %)
1 diff
(99.7 %id)
BQ938616 sciatic nerve .f 3529 to 4256 14 to 747       734/934
(78 %)
23 diff
(97.6 %id)
AW467683 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .f 3545 to 3719 175 to 1       175/175
(100 %)
2 diff
(98.9 %id)
CB152247 brain .f 3547 to 3980 1 to 438       438/438
(100 %)
3 diff
(99.4 %id)
AI913904 colon .f 3550 to 3833 285 to 2       284/285
(99 %)
0 diff
(100 %id)
H12123 whole brain .f 3558 to 3710 154 to 1       154/154
(100 %)
2 diff
(98.8 %id)
BU733568 eye, optic nerve .f 3562 to 3718 175 to 19   AAA   157/157
(100 %)
4 diff
(97.5 %id)
DA291249 hippocampus .f 3565 to 3998 2 to 437   capped   436/436
(100 %)
2 diff
(99.6 %id)
AW451169   .f 3575 to 3829 272 to 18   AAA   255/265
(96 %)
0 diff
(100 %id)
BF512931   .f 3575 to 3829 272 to 18   AAA   255/265
(96 %)
0 diff
(100 %id)
BX327733 Neuroblastoma Cot 50-normalized .f 3590 to 3720 19 to 152       134/155
(86 %)
6 diff
(96.2 %id)
BG987304 head_neck .f 3624 to 4104 1 to 478       478/478
(100 %)
41 diff
(91.5 %id)
CN343417 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 3659 to 4090 9 to 441       433/441
(98 %)
6 diff
(98.7 %id)
BM723844 eye, fetal eye .f 3776 to 4423 1 to 647     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 647/647
(100 %)
1 diff
(99.9 %id)
BE560028 Burkitt lymphoma, lymph .f 3800 to 4483 1 to 682       682/954
(71 %)
12 diff
(98.8 %id)
DN990147 brain, whole brain .f 3828 to 4433 9 to 613       605/613
(98 %)
6 diff
(99.1 %id)
TI_151798149   .f 3829 to 4444 711 to 96   AAA Submitted on the opposite strand 616/641
(96 %)
8 diff
(98.8 %id)
CA426249 Bone, Subchondral Bone .f 3839 to 4469 1 to 630     Submitted on the opposite strand 630/632
(99 %)
7 diff
(98.9 %id)
CB851369 lung, Primary Lung Epithelial Cells .f 3840 to 4476 14 to 650     Submitted on the opposite strand 637/650
(98 %)
6 diff
(99.1 %id)
BG055205 Prostate .f 3852 to 4342 1 to 468     Submitted on the opposite strand 468/468
(100 %)
32 diff
(93.2 %id)
AI337300 colon, colon tumor, RER+ .f 3866 to 4443 578 to 1       578/578
(100 %)
0 diff
(100 %id)
AL355720   .f 3891 to 5581 1 to 1691   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1691/1691
(100 %)
0 diff
(100 %id)
R61732 whole brain .f 3892 to 4319 1 to 440     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 440/442
(99 %)
26 diff
(94.2 %id)
DA158499 amygdala .f 3895 to 4447 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
BJ992868.
matches multiple genes
hepatoblastoma .f 3901 to 4408 508 to 1     also hits gene MST1 508/508
(100 %)
0 diff
(100 %id)
BG740038 skin .f 3916 to 4609 1 to 697       697/698
(99 %)
21 diff
(97.0 %id)
BG740655 skin .f 3916 to 4505 1 to 591       591/706
(83 %)
10 diff
(98.6 %id)
T61452 lung .f 3946 to 4444 502 to 1       502/504
(99 %)
15 diff
(97.1 %id)
AI913243 Kidney .f 3957 to 4465 509 to 1       509/509
(100 %)
0 diff
(100 %id)
F35476 pectoral muscle (after mastectomy) .f 3974 to 4265 1 to 292       292/292
(100 %)
3 diff
(99.0 %id)
AA412689   .f 3988 to 4447 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AA548529 adrenal adenoma, adrenal gland .f 3988 to 4444 455 to 1       455/455
(100 %)
2 diff
(99.6 %id)
EL952504 eyeball .f 3989 to 4305 13 to 330       318/330
(96 %)
6 diff
(98.2 %id)
AA603966 adrenal adenoma, adrenal gland .f 3990 to 4286 295 to 1       295/295
(100 %)
3 diff
(99.0 %id)
BP397707 pancreatic islet .f 3992 to 4444 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
BF590631 colon, colon tumor, RER+ .f 4016 to 4444 429 to 1       429/429
(100 %)
3 diff
(99.4 %id)
AW612382 Kidney .f 4023 to 4444 422 to 1       422/422
(100 %)
6 diff
(98.6 %id)
AI400089 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 4028 to 4443 415 to 1       415/415
(100 %)
1 diff
(99.8 %id)
BC004219 Eye, retinoblastoma .f 4035 to 5581 8 to 1554   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1547/1547
(100 %)
2 diff
(99.9 %id)
AI439292 lymph node, lymphoma, follicular mixed small and largecell .f 4046 to 4444 400 to 1       400/400
(100 %)
1 diff
(99.8 %id)
BE252085 eye, retinoblastoma .f 4047 to 4477 1 to 435   available from MGC,   435/550
(79 %)
12 diff
(97.9 %id)
AA782786 parathyroid gland, parathyroid tumor .f 4058 to 4450 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
BE856450 Prostate .f 4135 to 4450 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
AI150779 heart .f 4139 to 4446 308 to 1       308/308
(100 %)
2 diff
(99.4 %id)
DW437818 Liver .f 4163 to 4393 17 to 247       231/247
(93 %)
6 diff
(97.6 %id)
AK074300   .f 4165 to 6188 1 to 2025   available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2025/2025
(100 %)
3 diff
(99.9 %id)
BF591745 brain, glioblastoma (pooled) .f 4180 to 4465 287 to 1       287/287
(100 %)
5 diff
(98.3 %id)
AI351911 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 4188 to 4446 259 to 1       259/259
(100 %)
1 diff
(99.7 %id)
DA372536 thalamus .f 4208 to 4829 2 to 623   capped   622/622
(100 %)
0 diff
(100 %id)
BE084899 breast .f 4209 to 4440 232 to 1     Submitted on the opposite strand 232/232
(100 %)
0 diff
(100 %id)
GD137734   .f 4217 to 4443 1 to 227   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 227/227
(100 %)
2 diff
(99.2 %id)
CV029921 mixed .f 4218 to 4408 1 to 191       191/364
(52 %)
1 diff
(99.8 %id)
DA137979 alzheimer cortex .f 4245 to 4798 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BE735804 adenocarcinoma, Pancreas .f 4322 to 5086 1 to 767       767/898
(85 %)
55 diff
(93.9 %id)
DA359838 subthalamic nucleus .f 4331 to 4881 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
CD672869 eye, Iris .f 4345 to 4873 1 to 529       529/529
(100 %)
8 diff
(98.5 %id)
AL355721   .f 4364 to 5676 1 to 1313       1313/1313
(100 %)
5 diff
(99.7 %id)
R52763 whole brain .f 4365 to 4843 1 to 493       493/544
(90 %)
21 diff
(96.2 %id)
H05200 whole brain .f 4365 to 4543 1 to 179       179/179
(100 %)
0 diff
(100 %id)
AA211524 muscle, skeletal muscle .f 4388 to 4882 1 to 497       497/498
(99 %)
8 diff
(98.4 %id)
AA653951   .f 4415 to 4796 382 to 2       381/382
(99 %)
0 diff
(100 %id)
BE715088 head_neck .f 4416 to 4858 458 to 11       448/519
(86 %)
0 diff
(100 %id)
R60733 whole brain .f 4423 to 4879 1 to 460     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 460/461
(99 %)
15 diff
(96.8 %id)
AA369745 Pancreas .f 4430 to 4647 1 to 218       218/218
(100 %)
0 diff
(100 %id)
W96057 heart .f 4430 to 4861 1 to 439       439/444
(98 %)
11 diff
(97.6 %id)
BG675300 skin .f 4431 to 5183 1 to 777       777/915
(84 %)
53 diff
(94.3 %id)
BM475397 eye, retinoblastoma .f 4431 to 5117 13 to 707       695/1119
(62 %)
22 diff
(98.1 %id)
W78700 liver and spleen .f 4439 to 4832 31 to 435       405/435
(93 %)
5 diff
(98.9 %id)
CF139557 CNCAP(3)T-225 cell line, Prostate .f 4441 to 4955 7 to 519       513/519
(98 %)
6 diff
(98.9 %id)
TI_154169853   .f 4441 to 5058 86 to 710       625/999
(62 %)
17 diff
(98.3 %id)
BG741397 skin .f 4444 to 5105 1 to 661       661/665
(99 %)
27 diff
(96.0 %id)
BG743015 skin .f 4473 to 5196 1 to 723       723/728
(99 %)
10 diff
(98.7 %id)
Z41916 brain, total brain .f 4531 to 4730 1 to 200       200/200
(100 %)
1 diff
(99.5 %id)
T35230 prostate gland .f 4542 to 4753 1 to 212       212/212
(100 %)
0 diff
(100 %id)
AW953844   .f 4543 to 4975 1 to 436       436/457
(95 %)
9 diff
(98.1 %id)
AW954017   .f 4543 to 5177 1 to 634       634/635
(99 %)
22 diff
(96.6 %id)
BQ641367 eye, normal pigmented retinal epithelium .f 4601 to 5417 1 to 822       822/925
(88 %)
19 diff
(98.0 %id)
BQ939756 eye, normal pigmented retinal epithelium .f 4601 to 5458 1 to 869       869/977
(88 %)
19 diff
(98.1 %id)
BG910611 anaplastic oligodendroglioma with 1p/19qloss, brain .f 4660 to 5359 1 to 700       700/700
(100 %)
4 diff
(99.5 %id)
BU857003 adenocarcinoma, cell line, breast .f 4709 to 5448 1 to 749   AAA   749/911
(82 %)
18 diff
(98.1 %id)
BM694237 eye, RPE and Choroid .f 4734 to 5231 1 to 498   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 498/498
(100 %)
0 diff
(100 %id)
H78952 liver and spleen .f 4765 to 5091 1 to 326       326/327
(99 %)
5 diff
(98.5 %id)
TI_154110402   .f 4765 to 5581 868 to 57   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 812/961
(84 %)
7 diff
(99.3 %id)
BX283294 carcinoma, cell line, Prostate .f 4770 to 5289 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BM047479 carcinoma, cell line, Prostate .f 4770 to 5582 1 to 810       810/816
(99 %)
9 diff
(98.9 %id)
BU543126 carcinoma, cell line, Prostate .f 4774 to 5561 1 to 798       798/959
(83 %)
21 diff
(97.9 %id)
CD243243 brain, Pituitary .f 4806 to 5591 1 to 796       796/909
(87 %)
18 diff
(98.1 %id)
CA448137 Chondrosarcoma, Left Pubic Bone .f 4808 to 5581 790 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 772/772
(100 %)
4 diff
(99.5 %id)
BM680013 eye, fetal eye .f 4838 to 5581 762 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 744/744
(100 %)
1 diff
(99.9 %id)
BF338240 brain, glioblastoma with EGFR amplification .f 4901 to 5565 1 to 661       661/661
(100 %)
13 diff
(98.1 %id)
BU608761 Human Lung Epithelial cells, lung .f 4930 to 5581 671 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 653/653
(100 %)
2 diff
(99.7 %id)
BU622035 Cell Line, Chondrosarcoma .f 4930 to 5581 670 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 652/652
(100 %)
2 diff
(99.7 %id)
BF971460 adrenal cortex carcinoma, cell line, adrenal gland .f 4932 to 5698 1 to 763       763/809
(94 %)
16 diff
(98.1 %id)
AI823782 2 pooled tumors (clear cell type), Kidney .f 4988 to 5579 592 to 1       592/592
(100 %)
0 diff
(100 %id)
BF063240 colon, colon tumor, RER+ .f 5053 to 5583 532 to 2       531/532
(99 %)
0 diff
(100 %id)
AA211446 muscle, skeletal muscle .f 5055 to 5566 522 to 1       522/522
(100 %)
15 diff
(97.2 %id)
AI735628 aorta .f 5095 to 5579 488 to 4       485/488
(99 %)
0 diff
(100 %id)
AA158557 Pancreas .f 5096 to 5473 384 to 6       379/384
(98 %)
0 diff
(100 %id)
BF195170 brain, glioblastoma (pooled) .f 5103 to 5581 479 to 1       479/479
(100 %)
1 diff
(99.8 %id)
BQ688592 ductal carcinoma, cell line, Pancreas .f 5109 to 5994 1 to 893       893/894
(99 %)
12 diff
(98.7 %id)
DB551927 hippocampus .f 5110 to 5581 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
AI438984 B-cell, chronic lymphotic leukemia .f 5118 to 5587 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AW150275 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 5119 to 5581 480 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 463/463
(100 %)
4 diff
(99.2 %id)
AI087876 pooled .f 5120 to 5582 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AI935774 Kidney .f 5129 to 5504 378 to 3       376/378
(99 %)
0 diff
(100 %id)
AI817529 lymph node, lymphoma, follicular mixed small and largecell .f 5143 to 5595 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
CN484738 eye .f 5146 to 5589 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
AI473695 follicular lymphoma, lymph node .f 5146 to 5581 461 to 26   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 436/436
(100 %)
2 diff
(99.6 %id)
AI087089 senescent fibroblast .f 5148 to 5583 437 to 2       436/437
(99 %)
0 diff
(100 %id)
DB564265 hypothalamus .f 5157 to 5581 1 to 425     Submitted on the opposite strand 425/425
(100 %)
2 diff
(99.6 %id)
DB564266 hypothalamus .f 5157 to 5581 1 to 425     Submitted on the opposite strand 425/425
(100 %)
4 diff
(99.1 %id)
AA884830 pooled .f 5172 to 5584 427 to 15   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 413/413
(100 %)
3 diff
(99.3 %id)
AW663663 pooled .f 5175 to 5584 410 to 1       410/410
(100 %)
4 diff
(99.1 %id)
AI418312 pooled .f 5177 to 5586 409 to 1       409/420
(97 %)
3 diff
(99.3 %id)
AI034066 liver and spleen .f 5183 to 5596 415 to 2       414/415
(99 %)
0 diff
(100 %id)
W96078 heart .f 5184 to 5581 399 to 1       399/399
(100 %)
5 diff
(98.8 %id)
F36545 pectoral muscle (after mastectomy) .f 5184 to 5581 1 to 398   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 398/398
(100 %)
1 diff
(99.8 %id)
BU733106 eye, RPE and Choroid .f 5201 to 5581 399 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
AI220621 pooled .f 5206 to 5584 392 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 379/379
(100 %)
1 diff
(99.8 %id)
AI766879 2 pooled tumors (clear cell type), Kidney .f 5210 to 5583 375 to 2       374/375
(99 %)
0 diff
(100 %id)
AW050736 colon, colonic mucosa from 3 patients with Crohn'sdisease .f 5210 to 5587 380 to 3       378/380
(99 %)
0 diff
(100 %id)
F30855 pectoral muscle (after mastectomy) .f 5217 to 5386 1 to 170       170/170
(100 %)
0 diff
(100 %id)
DB562465 hypothalamus .f 5221 to 5581 1 to 360     Submitted on the opposite strand 360/360
(100 %)
10 diff
(97.3 %id)
W80500 liver and spleen .f 5227 to 5596 373 to 2       496/530
(93 %)
25 diff
(95.3 %id)
BF590062 Kidney .f 5238 to 5583 346 to 1       346/346
(100 %)
0 diff
(100 %id)
R61733 whole brain .f 5260 to 5581 339 to 13   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 327/327
(100 %)
8 diff
(97.6 %id)
AI759969 Kidney .f 5260 to 5575 337 to 22   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 316/316
(100 %)
8 diff
(97.5 %id)
R60734 whole brain .f 5270 to 5584 327 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 317/328
(96 %)
2 diff
(99.4 %id)
AA069262 Pancreas .f 5289 to 5499 215 to 1       215/215
(100 %)
6 diff
(97.3 %id)
N39657 melanocyte .f 5292 to 5819 1 to 535       535/560
(95 %)
15 diff
(97.4 %id)
TI_227713552   .f 5301 to 6188 941 to 60   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 882/1000
(88 %)
9 diff
(99.1 %id)
AW016215   .f 5306 to 5595 307 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 290/290
(100 %)
0 diff
(100 %id)
BF448081 Kidney .f 5353 to 5606 254 to 1       254/254
(100 %)
1 diff
(99.7 %id)
Z38210 brain, total brain .f 5376 to 5581 206 to 1       206/206
(100 %)
0 diff
(100 %id)
CB852026 Human Lung Epithelial cells, lung .f 5376 to 5581 1 to 206   AAA Submitted on the opposite strand 206/206
(100 %)
6 diff
(97.1 %id)
BM706456 eye, eye anterior segment .f 5421 to 5887 4 to 470   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 467/470
(99 %)
11 diff
(97.7 %id)
CD364521 Alveolar Macrophage, lung .f 5488 to 6188 716 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 701/701
(100 %)
0 diff
(100 %id)
BU934367 mixed (pool of 40 RNAs) .f 5500 to 6168 1 to 672       672/874
(76 %)
38 diff
(95.7 %id)
BF447596 carcinoid, lung .f 5502 to 6011 1 to 510     Submitted on the opposite strand 510/510
(100 %)
0 diff
(100 %id)
BQ027200 lung, Metastatic Chondrosarcoma .f 5505 to 6180 692 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 676/676
(100 %)
5 diff
(99.3 %id)
AI928403 Kidney .f 5568 to 6186 619 to 1       619/619
(100 %)
2 diff
(99.7 %id)
AA640740   .f 5586 to 5983 1 to 398       398/398
(100 %)
7 diff
(98.3 %id)
CB122252 Liver .f 5603 to 6192 609 to 20   AAA Submitted on the opposite strand 590/590
(100 %)
2 diff
(99.7 %id)
BQ021676 lung, Metastatic Chondrosarcoma .f 5610 to 6188 595 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
BX118173 liver and spleen .f 5621 to 6188 1 to 566   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 566/566
(100 %)
2 diff
(99.7 %id)
H78495 liver and spleen .f 5622 to 5959 1 to 344   fully sequenced,   344/344
(100 %)
3 diff
(99.2 %id)
AA009853 heart .f 5627 to 6128 1 to 502       502/504
(99 %)
3 diff
(99.5 %id)
DB550894 hippocampus .f 5659 to 6178 1 to 521     Submitted on the opposite strand 521/521
(100 %)
1 diff
(99.9 %id)
BM695286 eye, optic nerve .f 5662 to 6178 1 to 518   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 518/518
(100 %)
1 diff
(99.9 %id)
AA004807 liver and spleen .f 5666 to 6175 512 to 1       512/512
(100 %)
7 diff
(98.7 %id)
AI857752 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 5681 to 6183 509 to 7       503/509
(98 %)
0 diff
(100 %id)
AA777475 liver and spleen .f 5684 to 6188 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AA535859 colon .f 5688 to 6175 488 to 1       488/499
(97 %)
3 diff
(99.4 %id)
CB047262 Kidney .f 5688 to 6180 515 to 23   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 493/502
(98 %)
1 diff
(99.9 %id)
D20032   .f 5692 to 6173 1 to 491     Submitted on the opposite strand 491/500
(98 %)
15 diff
(97.0 %id)
TI_151742427   .f 5695 to 6186 607 to 110       498/1109
(44 %)
0 diff
(100 %id)
AI640829 Kidney .f 5700 to 6182 483 to 1       483/483
(100 %)
0 diff
(100 %id)
BM666454 eye, optic nerve .f 5707 to 6178 490 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 472/472
(100 %)
0 diff
(100 %id)
BE222602 brain, oligodendroglioma .f 5717 to 6188 475 to 4       472/475
(99 %)
0 diff
(100 %id)
AA565419 germ cell tumor .f 5721 to 6176 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
TI_154192704   .f 5737 to 6186 49 to 497   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 449/449
(100 %)
1 diff
(99.8 %id)
AW972182   .f 5738 to 6170 447 to 8     Submitted on the opposite strand 440/495
(88 %)
0 diff
(100 %id)
AA595222 breast .f 5739 to 6179 441 to 1       441/441
(100 %)
0 diff
(100 %id)
CF130692 Chondrosarcoma Lung Metastasis cell lines, lung .f 5740 to 6186 1 to 447   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 447/447
(100 %)
2 diff
(99.6 %id)
BF435443 pooled .f 5745 to 6183 441 to 3       439/449
(97 %)
0 diff
(100 %id)
AI823419 Kidney .f 5747 to 6183 441 to 5       437/441
(99 %)
0 diff
(100 %id)
BF439737 carcinoid, lung .f 5750 to 6183 440 to 7       434/440
(98 %)
0 diff
(100 %id)
DB532005 hippocampus .f 5751 to 6185 1 to 435     Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
AI885514 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 5753 to 6188 445 to 9       437/445
(98 %)
0 diff
(100 %id)
AI083999 senescent fibroblast .f 5754 to 6175 440 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
AI985491 Kidney .f 5754 to 6180 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AW292423   .f 5754 to 6183 444 to 15       430/444
(96 %)
0 diff
(100 %id)
BM988699 lung, Lung Focal Fibrosis .f 5754 to 6183 445 to 16       430/445
(96 %)
0 diff
(100 %id)
CB148986 Liver .f 5755 to 6178 1 to 424   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
AI279020 carcinoid, lung .f 5762 to 6180 439 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 419/419
(100 %)
1 diff
(99.8 %id)
AW613527 carcinoid, lung .f 5769 to 6183 417 to 3       415/417
(99 %)
0 diff
(100 %id)
BF435782 pooled .f 5778 to 6183 408 to 3       406/408
(99 %)
0 diff
(100 %id)
R52764 whole brain .f 5780 to 6183 411 to 1       411/516
(79 %)
12 diff
(97.7 %id)
AA564204 germ cell tumor .f 5780 to 6176 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
AI753248 bone marrow stroma .f 5786 to 6178 411 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
N55406 multiple sclerosis lesions .f 5803 to 5995 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BP420145 small intestine .f 5804 to 6188 1 to 386     Submitted on the opposite strand 386/387
(99 %)
5 diff
(98.8 %id)
BX099446 Kidney .f 5817 to 6212 1 to 395       395/395
(100 %)
2 diff
(99.5 %id)
BF092809 testis_normal .f 5821 to 6166 1 to 341       341/341
(100 %)
8 diff
(97.7 %id)
AI092504 heart .f 5827 to 6179 355 to 2       354/355
(99 %)
0 diff
(100 %id)
BF939383 fibrotheoma, ovary .f 5832 to 6186 367 to 13   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 355/355
(100 %)
1 diff
(99.8 %id)
BF092818 testis_normal .f 5835 to 6151 9 to 321       313/321
(97 %)
6 diff
(98.2 %id)
AA283177 ovarian tumor, ovary .f 5841 to 6181 341 to 1       341/341
(100 %)
0 diff
(100 %id)
BM673284 eye, eye anterior segment .f 5857 to 6180 342 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 324/324
(100 %)
2 diff
(99.4 %id)
AA815020 germinal center B cell .f 5865 to 6175 350 to 40   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
CA311792 Human Lung Epithelial cells, lung .f 5873 to 6640 775 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 762/762
(100 %)
10 diff
(98.7 %id)
D53118 brain .f 5884 to 6180 1 to 297   fully sequenced,   297/297
(100 %)
1 diff
(99.7 %id)
D53654   .f 5884 to 6180 1 to 298   fully sequenced,   298/298
(100 %)
3 diff
(99.0 %id)
D55869   .f 5884 to 6176 1 to 292       292/295
(98 %)
2 diff
(99.4 %id)
BF821834 kidney_tumor .f 5926 to 6103 1 to 176       176/176
(100 %)
1 diff
(99.5 %id)
H78397 liver and spleen .f 5929 to 6194 284 to 4   fully sequenced,   281/284
(98 %)
8 diff
(97.2 %id)
BF513743   .f 5939 to 6183 258 to 13       246/259
(94 %)
0 diff
(100 %id)
BQ020254 Chondrosarcoma, Left Pubic Bone .f 5962 to 6616 671 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 658/658
(100 %)
4 diff
(99.4 %id)
AA370199 Prostate .f 5964 to 6186 223 to 1       223/223
(100 %)
0 diff
(100 %id)
AI640477 Kidney .f 5984 to 6187 208 to 5       204/208
(98 %)
0 diff
(100 %id)
D80721 brain .f 5987 to 6180 191 to 1   fully sequenced,   191/191
(100 %)
4 diff
(98.0 %id)
D60545   .f 6017 to 6168 151 to 1   fully sequenced,   151/151
(100 %)
3 diff
(98.1 %id)
AI770007 Kidney .f 6065 to 6633 570 to 2   tiling clone,   569/570
(99 %)
0 diff
(100 %id)
AA443639 ovarian tumor, ovary .f 6072 to 6181 110 to 1       110/110
(100 %)
1 diff
(99.1 %id)
F34977 pectoral muscle (after mastectomy) .f 6184 to 6509 1 to 324       324/324
(100 %)
4 diff
(98.8 %id)
BM554306 brain, medulla .g 1 to 716 80 to 807   tiling clone,   726/1156
(62 %)
32 diff
(97.3 %id)
BI832205 brain, medulla .g 26 to 869 31 to 879   tiling clone,   849/879
(96 %)
19 diff
(97.9 %id)
TI_57175359   .g 26 to 869 31 to 879       849/879
(96 %)
19 diff
(97.9 %id)
BI461535 testis .g 37 to 723 6 to 694   tiling clone,   689/865
(79 %)
27 diff
(96.9 %id)
BP348457 brain .g 837 to 1424 1 to 588   tiling clone,   588/588
(100 %)
2 diff
(99.7 %id)
AI366140 brain, meningioma .g 911 to 1362 479 to 28       452/479
(94 %)
0 diff
(100 %id)
DA741132   .h 1 to 475 2 to 479   tiling clone, capped   478/489
(97 %)
5 diff
(99.0 %id)
DB324708   .h 2867 to 3373 507 to 1   tiling clone,   507/507
(100 %)
1 diff
(99.9 %id)
AA406110 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 1 to 430 434 to -3   tiling clone,   434/446
(97 %)
7 diff
(98.5 %id)
DA999676 breast, tumor tissue .i 200 to 758 2 to 561   tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
AF156775   .i 213 to 1722 1 to 1508 exact tiling clone, AAA   1508/1508
(100 %)
2 diff
(99.9 %id)
BQ072125 brain, neuroblastoma, cell line .i 284 to 1249 1 to 983   tiling clone,   981/985
(99 %)
26 diff
(97.4 %id)
BM563288 brain, medulla .j 1 to 902 21 to 924   tiling clone,   904/1107
(81 %)
23 diff
(98.0 %id)
BF062652 colon, colon tumor, RER+ .j 419 to 965 546 to 1   tiling clone,   546/546
(100 %)
10 diff
(98.2 %id)
CR992151 T-Lymphocytes .j 855 to 1127 1 to 273   tiling clone, AAA   273/273
(100 %)
0 diff
(100 %id)
CT000240 T-Lymphocytes .k 1 to 523 1 to 523 G158X K165X V171X tiling clone,   523/530
(98 %)
1 diff
(99.9 %id)
BP218695 caudate nucleus .l 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BP218727 caudate nucleus .l 1 to 582 1 to 582 G103S     582/582
(100 %)
6 diff
(99.0 %id)
TI_57174951   .m 1 to 780 22 to 803 exact tiling clone,   782/805
(97 %)
16 diff
(98.1 %id)
BI828224 brain, medulla .m 8 to 780 1 to 775 exact tiling clone,   775/777
(99 %)
8 diff
(99.0 %id)
AW466930 2 pooled tumors (clear cell type), Kidney .n 1 to 349 350 to 2 T114H M115K tiling clone,   349/350
(99 %)
0 diff
(100 %id)
AW466871 2 pooled tumors (clear cell type), Kidney .n 148 to 349 203 to 2       202/203
(99 %)
1 diff
(99.6 %id)
AV659333 corresponding non cancerous liver tissue .o 1 to 413 1 to 413     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
AV659375 corresponding non cancerous liver tissue .o 1 to 394 1 to 394     Submitted on the opposite strand 394/404
(97 %)
0 diff
(100 %id)
AV659533 corresponding non cancerous liver tissue .o 1 to 454 1 to 454 exact tiling clone, Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
CN428830 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 1 to 498 1 to 498 exact tiling clone,   498/498
(100 %)
0 diff
(100 %id)
BI827693 brain, medulla .q 1 to 791 1 to 789 C22V D23* tiling clone,   789/789
(100 %)
17 diff
(97.9 %id)
TI_57171931   .q 1 to 791 73 to 861 C22V D23*     789/861
(91 %)
22 diff
(97.5 %id)
BP431792   .r 1 to 430 1 to 430 exact tiling clone,   430/430
(100 %)
3 diff
(99.4 %id)
BM050797 eye, normal pigmented retinal epithelium .s-u 1 to 823 1 to 803   tiling clone,   803/803
(100 %)
25 diff
(96.9 %id)
BQ574319 Chondrosarcoma Grade II, Left Pelvis .t-u 1 to 683 701 to 19 exact tiling clone, AAA   683/683
(100 %)
1 diff
(99.9 %id)
CN343414 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .u 1 to 616 1 to 617 S101V D102G Y103L tiling clone,   617/618
(99 %)
2 diff
(99.7 %id)
DA524876 brain Gene AGPAT3, variant not shown       capped, AAA Suspected internal deletion, this clone was ignored    
AK300562 Prostate Gene AGPAT3, variant not shown         Suspected internal deletion, this clone was ignored    
AY358704   Gene AGPAT3, variant not shown         This clone was ignored    
AI913237 Kidney Gene AGPAT3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t-u, .u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C